Indication

Anaemia with chronic kidney disease

RAG rating

Red

Document type

Decision document

Place

Hertfordshire and West Essex ICB

Output type

Pharmacy / Prescribing

Erythropoiesis stimulating agents

HERTFORDSHIRE AND WEST ESSEX AREA PRESCRIBING COMMITTEE (HWE APC)

Erythropoiesis stimulating agents for the treatment of symptomatic anaemia associated with

chronic kidney disease

RED

Recommended for restricted prescribing by specialist only

Not recommended for primary care prescribing

Name generic (trade) Erythropoiesis stimulating agents

What it is Erythropoiesis stimulating agents

Indication Licensed for the treatment of adult patients with symptomatic anaemia associated with chronic renal failure

Date decision last revised September 2022

Decision status Final

NICE / SMC Guidance NICE NG 203 recommended

HWE APC recommendation:

Erythropoiesis stimulating agents are recommended for restricted use as an option for the treatment of adult patients with symptomatic anaemia associated with chronic kidney disease in line with the recommendations in NICE NG 203

Review date: The recommendation is based upon the evidence available at the time of publication. This recommendation will be reviewed upon request in the light of new evidence becoming available.